Drug:
Reaction: OVERDOSE
20250101 - 20251231
No. 4501 - 4600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 4501 | 24899182 |
US |
2 | |
Overdose, Psychotic disorder, Suicidal ideation, |
||||
CLOZAPINE, ACETAMINOPHEN, ASPRIN, CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, CAFFEINE, |
||||
| 4502 | 24899427 |
CN |
39 | 1 |
Off label use, Drug interaction, Coma, Overdose, |
||||
BACLOFEN, CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE, |
||||
| 4503 | 24899441 |
DE |
68 | 1 |
Rash, Overdose, Adverse drug reaction, |
||||
FOSCARBIDOPA/FOSLEVODOPA, RASAGILINE MESYLATE, RASAGILINE, |
||||
| 4504 | 24899450 |
SE |
89 | 1 |
Seizure, Overdose, Urinary retention, |
||||
ALLOPURINOL, FUROSEMIDE, |
||||
| 4505 | 24900414 |
US |
43 | 1 |
Product name confusion, Wrong product administered, Overdose, |
||||
IBUPROFEN AND DIPHENHYDRAMINE CITRATE, |
||||
| 4506 | 24900421 |
US |
2 | |
Off label use, Overdose, |
||||
IBUPROFEN AND DIPHENHYDRAMINE CITRATE, |
||||
| 4507 | 24901049 |
FR |
84 | 2 |
Respiratory distress, Lactic acidosis, Acute kidney injury, Atrioventricular block complete, Drug interaction, Overdose, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, BISOPROLOL FUMARATE, DIGOXIN, BISOPROLOL FUMARATE, APIXABAN, IRBESARTAN, DAPAGLIFLOZIN, FUROSEMIDE, PAROXETINE HYDROCHLORIDE, TAFAMIDIS, PREGABALIN, LEVOTHYROXINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 4508 | 24901101 |
US |
6 | 2 |
Product preparation issue, Incorrect drug administration rate, Circumstance or information capable of leading to medication error, Overdose, Water intoxication, Hyponatraemia, Brain oedema, Brain herniation, Brain compression, Generalised tonic-clonic seizure, Vomiting, |
||||
DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE, |
||||
| 4509 | 24901118 |
FR |
41 | 1 |
Drug use disorder, Overdose, |
||||
| 4510 | 24901232 |
US |
1 | |
Overdose, Drug dependence, Drug abuse, Injury, Emotional distress, Pain, Impaired quality of life, Drug withdrawal syndrome, Counterfeit product administered, Unevaluable event, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, BUPRENORPHINE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, HYDROCODONE BITARTRATE, FENTANYL, |
||||
| 4511 | 24901375 |
US |
||
Overdose, Off label use, |
||||
INCOBOTULINUMTOXINA, |
||||
| 4512 | 24892350 |
39 | 1 | |
Drug interaction, Coma, Overdose, Product use in unapproved indication, |
||||
BACLOFEN, BACLOFEN, BACLOFEN, CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE, PERPHENAZINE, OXALIPLATIN, CAPECITABINE, |
||||
| 4513 | 24892508 |
US |
2 | |
Drug ineffective for unapproved indication, Inappropriate schedule of product administration, Overdose, Incorrect product administration duration, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 4514 | 24892575 |
CA |
43 | 1 |
Antemortem blood drug level abnormal, Overdose, Postmortem blood drug level abnormal, Toxicity to various agents, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CARBAMAZEPINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHADONE, FENTANYL, NALOXONE, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, |
||||
| 4515 | 24892600 |
FR |
28 | 2 |
Hepatitis fulminant, Poisoning deliberate, Overdose, |
||||
ALPRAZOLAM, KETOPROFEN, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SERTRALINE HYDROCHLORIDE, |
||||
| 4516 | 24892653 |
US |
16 | 1 |
Loss of consciousness, Overdose, Drug abuse, |
||||
AMPHETAMINE, FENTANYL, |
||||
| 4517 | 24892786 |
CA |
40 | 2 |
Systemic lupus erythematosus, Decreased appetite, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Sleep disorder, Stomatitis, Swelling, Synovitis, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Underdose, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Hypersensitivity, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Onychomycosis, Osteoarthritis, Overdose, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, |
||||
DICLOFENAC SODIUM, ERENUMAB-AOOE, APREMILAST, CELECOXIB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PHENYLEPHRINE HYDROCHLORIDE, GOLIMUMAB, GOLIMUMAB, AZATHIOPRINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, CELECOXIB, APREMILAST, GOLIMUMAB, GOLIMUMAB, PREDNISONE, INFLIXIMAB, RITUXIMAB, |
||||
| 4518 | 24893093 |
AU |
||
Neurogenic bladder, Rheumatoid arthritis, COVID-19, Blood test abnormal, Arthropathy, Limb discomfort, Lumbosacral plexopathy, Mass, Perineal rash, Muscular weakness, Herpes zoster, Overdose, Drug ineffective, Inappropriate schedule of product administration, Incorrect route of product administration, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, RITUXIMAB, TOCILIZUMAB, UPADACITINIB, BARICITINIB, ABATACEPT, |
||||
| 4519 | 24893104 |
US |
58 | 1 |
CHANTER syndrome, Overdose, |
||||
FENTANYL, |
||||
| 4520 | 24893200 |
2 | ||
Urinary retention, Status epilepticus, Sepsis, Acute respiratory distress syndrome, Aspiration, Bundle branch block left, Lung consolidation, Metabolic acidosis, Bradycardia, Skin warm, Dry skin, Hypothermia, Seizure, Electrocardiogram QRS complex prolonged, Electrocardiogram QT prolonged, Rhabdomyolysis, Sinus tachycardia, Atrioventricular block first degree, Coma scale abnormal, Hypotension, Toxicity to various agents, Overdose, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 4521 | 24893585 |
BR |
||
Crohn^s disease, Dengue fever, Overdose, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, AZATHIOPRINE, |
||||
| 4522 | 24893698 |
US |
2 | |
Eye degenerative disorder, Incorrect dose administered, Overdose, Product dose omission issue, Device delivery system issue, Wrong technique in device usage process, Unevaluable event, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
| 4523 | 24893725 |
FR |
||
Diarrhoea, Hepatic cytolysis, Intentional product use issue, Overdose, |
||||
TRASTUZUMAB, TUCATINIB, CAPECITABINE, |
||||
| 4524 | 24893860 |
RU |
59 | 1 |
Agranulocytosis, Pancytopenia, Multiple organ dysfunction syndrome, Haemorrhagic disorder, Overdose, |
||||
METHOTREXATE, METHOTREXATE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 4525 | 24893951 |
63 | 1 | |
Nausea, Vomiting, Unresponsive to stimuli, Overdose, Mental status changes, Dyspnoea, Sinus tachycardia, Urinary tract infection, Urosepsis, Electrocardiogram ST-T segment depression, Troponin I increased, Arteriosclerosis, Iliac artery stenosis, Peripheral artery thrombosis, Conduction disorder, |
||||
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, LEUCOVORIN CALCIUM, |
||||
| 4526 | 24894139 |
CA |
2 | |
Depression, Overdose, |
||||
UPADACITINIB, HYDROXYZINE, |
||||
| 4527 | 24894312 |
US |
63 | 1 |
Overdose, |
||||
DULAGLUTIDE, |
||||
| 4528 | 24894454 |
US |
||
Inappropriate schedule of product administration, Overdose, |
||||
FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE CHEWABLE TABLET, FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE, |
||||
| 4529 | 24894709 |
AU |
||
Rheumatoid arthritis, Neurogenic bladder, Arthropathy, Blood test abnormal, COVID-19, Limb discomfort, Lumbosacral plexopathy, Mass, Muscular weakness, Perineal rash, Herpes zoster, Drug ineffective, Overdose, Inappropriate schedule of product administration, Incorrect route of product administration, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, UPADACITINIB, TOCILIZUMAB, BARICITINIB, ABATACEPT, RITUXIMAB, |
||||
| 4530 | 24894790 |
US |
1 | |
Impaired driving ability, Hepatitis C, Overdose, Toxicity to various agents, Drug dependence, Drug abuse, Injury, Emotional distress, Post-traumatic stress disorder, Drug diversion, Pain, Homicide, Prescription drug used without a prescription, |
||||
OXYCODONE HYDROCHLORIDE, |
||||
| 4531 | 24895769 |
FR |
21 | 2 |
Drug use disorder, Overdose, |
||||
| 4532 | 24895806 |
US |
39 | 2 |
Gastrointestinal disorder, Overdose, Injection site pain, Diarrhoea, |
||||
RIOCIGUAT, AMBRISENTAN, SOTATERCEPT-CSRK, |
||||
| 4533 | 24896227 |
FR |
59 | 2 |
Confusional state, Hallucination, visual, Overdose, |
||||
VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, BASILIXIMAB, BASILIXIMAB, CYCLOSPORINE, AMIKACIN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE, CEFEPIME, PROPOFOL, MORPHINE, |
||||
| 4534 | 24896260 |
GB |
||
Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 4535 | 24896295 |
US |
27 | 1 |
Overdose, Intentional product misuse, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ALPRAZOLAM, LORAZEPAM, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, ALPRAZOLAM, |
||||
| 4536 | 24896308 |
US |
1 | |
Drug dependence, Overdose, Emotional distress, Mental disorder, Pain, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, MORPHINE SULFATE, MORPHINE SULFATE, HYDROMORPHONE HYDROCHLORIDE, |
||||
| 4537 | 24896309 |
US |
38 | 1 |
Overdose, Mental disorder, |
||||
| 4538 | 24896391 |
US |
71 | 1 |
Psoriasis, Inappropriate schedule of product administration, Overdose, |
||||
IXEKIZUMAB, IXEKIZUMAB, |
||||
| 4539 | 24896555 |
US |
2 | |
Overdose, |
||||
INSULIN GLARGINE, |
||||
| 4540 | 24887453 |
CO |
||
Malaise, Eyelid oedema, Tachycardia, Blood pressure increased, Dyspnoea, Chest pain, Vomiting, Erythema, Pruritus, Lip oedema, Back pain, Pain in extremity, Incorrect product administration duration, Overdose, |
||||
INFLIXIMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 4541 | 24887503 |
US |
1 | |
Transplant, Overdose, |
||||
SUCROFERRIC OXYHYDROXIDE, |
||||
| 4542 | 24887990 |
US |
17 | 1 |
Back pain, Brain oedema, Drug abuse, Drug interaction, Overdose, Pulmonary oedema, Toxicity to various agents, Vomiting, |
||||
CAFFEINE, MORPHINE SULFATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 4543 | 24888063 |
US |
1 | |
Overdose, Cardiopulmonary failure, Unresponsive to stimuli, Cyanosis, |
||||
AMPHETAMINE, FENTANYL, METHADONE, |
||||
| 4544 | 24888153 |
US |
1 | |
Overdose, |
||||
| 4545 | 24888202 |
AU |
2 | |
Completed suicide, Overdose, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, TEMAZEPAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), PROPRANOLOL HYDROCHLORIDE, |
||||
| 4546 | 24888234 |
GB |
||
Retrograde ejaculation, Abdominal pain upper, Micturition urgency, Drug interaction, Dizziness, Overdose, Product use issue, |
||||
APIXABAN, LISINOPRIL, ALLOPURINOL, |
||||
| 4547 | 24888334 |
US |
1 | |
Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 4548 | 24888677 |
US |
81 | 1 |
Gout, Overdose, Product storage error, |
||||
DUPILUMAB, DUPILUMAB, GABAPENTIN, |
||||
| 4549 | 24888699 |
ES |
1 | |
Overdose, Depressed level of consciousness, Incorrect drug administration rate, |
||||
MORPHINE, |
||||
| 4550 | 24888815 |
US |
1 | |
Overdose, Toxicity to various agents, |
||||
ALPRAZOLAM, FENTANYL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 4551 | 24888832 |
US |
37 | 2 |
Seizure, Hot flush, Hyperhidrosis, Pyrexia, Memory impairment, Incorrect dose administered, Overdose, |
||||
LACOSAMIDE, LACOSAMIDE, LEVETIRACETAM, DIVALPROEX SODIUM, |
||||
| 4552 | 24889199 |
US |
22 | 2 |
Overdose, Death, Pruritus, |
||||
AMPHETAMINE, FENTANYL, GABAPENTIN, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, |
||||
| 4553 | 24889308 |
FR |
84 | 2 |
Atrioventricular block complete, Respiratory distress, Lactic acidosis, Acute kidney injury, Overdose, Drug interaction, Drug interaction, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, BISOPROLOL FUMARATE, DIGOXIN, APIXABAN, IRBESARTAN, DAPAGLIFLOZIN, FUROSEMIDE, PAROXETINE HYDROCHLORIDE, TAFAMIDIS, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 4554 | 24889450 |
KR |
||
Toxicity to various agents, Overdose, |
||||
FENTANYL, |
||||
| 4555 | 24889531 |
US |
37 | 2 |
Brain operation, Seizure, Headache, Fatigue, Overdose, |
||||
BRIVARACETAM, |
||||
| 4556 | 24889648 |
CA |
77 | 2 |
Acute respiratory failure, Respiratory depression, Acute kidney injury, Altered state of consciousness, Overdose, |
||||
GABAPENTIN, GABAPENTIN, BACLOFEN, BACLOFEN, |
||||
| 4557 | 24889758 |
US |
||
Drug ineffective, Overdose, |
||||
INCOBOTULINUMTOXINA, |
||||
| 4558 | 24890036 |
GB |
2 | |
Overdose, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 4559 | 24890237 |
US |
2 | 1 |
Overdose, Accidental exposure to product by child, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 4560 | 24890241 |
US |
12 | |
Overdose, Accidental exposure to product by child, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 4561 | 24890246 |
US |
2 | 1 |
Overdose, Accidental exposure to product by child, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 4562 | 24890264 |
US |
3 | 2 |
Overdose, Underdose, Off label use, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 4563 | 24890482 |
US |
2 | |
Toxicity to various agents, Overdose, Drug dependence, |
||||
MORPHINE SULFATE, |
||||
| 4564 | 24890668 |
CA |
40 | 2 |
Inflammation, Injury, Intentional product use issue, Liver function test increased, Mobility decreased, Muscular weakness, Neck pain, Off label use, Overdose, Pain in extremity, Bursitis, Pneumonia, Underdose, Fall, Finger deformity, Folliculitis, Gastrooesophageal reflux disease, Hepatitis, Hypoaesthesia, Incorrect product administration duration, |
||||
TRAMADOL HYDROCHLORIDE, LEFLUNOMIDE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, TOCILIZUMAB, FOLIC ACID, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, LAMOTRIGINE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE HYDROCHLORIDE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ERENUMAB-AOOE, MEPOLIZUMAB, ABATACEPT, OXYCODONE, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, SULFASALAZINE, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, TETRACYCLINE HYDROCHLORIDE, TOCILIZUMAB, LEFLUNOMIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, USTEKINUMAB, TOFACITINIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, RITUXIMAB, RITUXIMAB-ABBS, PREDNISONE, APREMILAST, |
||||
| 4565 | 24891392 |
CN |
16 | 1 |
Altered state of consciousness, Palpitations, Overdose, Flushing, |
||||
LEVOTHYROXINE SODIUM, |
||||
| 4566 | 24891495 |
US |
||
Overdose, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, |
||||
| 4567 | 24891814 |
US |
1 | |
Seizure, Fall, Overdose, Product dose omission issue, |
||||
BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, ACETAMINOPHEN, ASPRIN, CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, CAFFEINE, |
||||
| 4568 | 24886523 |
US |
12 | |
Overdose, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, |
||||
| 4569 | 24885845 |
CA |
||
Crohn^s disease, Diarrhoea, Intentional product use issue, Overdose, Blood iron decreased, |
||||
| 4570 | 24885964 |
CA |
27 | 1 |
Fall, Overdose, Skin laceration, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, INFLIXIMAB, |
||||
| 4571 | 24881275 |
FR |
77 | 2 |
Lactic acidosis, Overdose, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 4572 | 24881286 |
GB |
26 | 2 |
Alopecia universalis, Loss of libido, Maternal exposure during breast feeding, Maternal exposure during pregnancy, Overdose, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LACOSAMIDE, |
||||
| 4573 | 24881322 |
US |
58 | 2 |
Hypoxia, Hypotension, Soft tissue infection, Catheter site infection, Bacterial infection, Infusion site swelling, Infusion site erythema, Vomiting, Weight decreased, Infusion site pain, Overdose, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, AMBRISENTAN, RIOCIGUAT, ACETAMINOPHEN, KETAMINE HYDROCHLORIDE, CLONIDINE, KETOPROFEN, OXYGEN, 0XYGEN, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, AMITRIPTYLINE HYDROCHLORIDE, GABAPENTIN, LORATADINE, LORATADINE ORAL, ONDANSETRON HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, CEPHALEXIN, CEPHALEXIN, FUROSEMIDE, |
||||
| 4574 | 24881371 |
CA |
58 | 2 |
Cardiac failure, Foetal death, Coeliac disease, Bursitis, Fatigue, Fluid retention, Food allergy, Immunodeficiency, Infusion related reaction, Upper respiratory tract infection, Joint swelling, Rheumatoid arthritis, Temperature regulation disorder, Retching, Decreased immune responsiveness, Erythema, Drug intolerance, Hyponatraemia, Thrombocytopenia, Infection, Pyrexia, Psoriasis, Hypertension, Hypersensitivity, Hyperhidrosis, Rash erythematous, Pain, Headache, Constipation, Back pain, Nausea, Rash, Drug hypersensitivity, Asthma, Hepatic enzyme increased, Intentional product misuse, Contraindicated product administered, Product use issue, Off label use, Exposure during pregnancy, Treatment failure, Overdose, Drug ineffective, Prescribed overdose, |
||||
ABACAVIR SULFATE, ABACAVIR SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, CLONIDINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CITALOPRAM, CITALOPRAM HYDROBROMIDE, PROGESTERONE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MEPERIDINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DOLUTEGRAVIR SODIUM, ETANERCEPT, FLUCONAZOLE, FUROSEMIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, GABAPENTIN, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MORPHINE, MORPHINE SULFATE, MOXIFLOXACIN HYDROCHLORIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ABATACEPT, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PROGESTERONE, QUETIAPINE FUMARATE, QUETIAPINE, RITUXIMAB, RANITIDINE, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, TEMAZEPAM, SENNOSIDES, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, SENNA LEAF, SENNA LEAF, TEMAZEPAM, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ALBUTEROL SULFATE, BUPROPION HYDROCHLORIDE, PREGABALIN, TOFACITINIB, TOFACITINIB, |
||||
| 4575 | 24881486 |
CA |
36 | 2 |
Exposure during pregnancy, Foetal death, Infusion related reaction, Intentional product misuse, Off label use, Overdose, Pain, Prescribed overdose, Product use issue, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, ABACAVIR SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, CLONIDINE HYDROCHLORIDE, CLONIDINE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ETANERCEPT, FUROSEMIDE, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, MOXIFLOXACIN HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ABATACEPT, PROGESTERONE, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, TEMAZEPAM, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, SENNA LEAF, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, MONTELUKAST SODIUM, TEMAZEPAM, TOCILIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, ALBUTEROL SULFATE, BUPROPION HYDROCHLORIDE, |
||||
| 4576 | 24881899 |
CA |
2 | |
Exposure during pregnancy, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Immunodeficiency, Infusion related reaction, Joint swelling, Off label use, Overdose, Pain, Prescribed overdose, Intentional product misuse, Product use issue, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, ALBUTEROL SULFATE, ALBUTEROL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TOCILIZUMAB, VALPROATE SODIUM, ALBUTEROL SULFATE, ALBUTEROL, SENNA LEAF, |
||||
| 4577 | 24882355 |
US |
21 | |
Suicide attempt, Overdose, Serotonin syndrome, Pupillary reflex impaired, |
||||
SERTRALINE HYDROCHLORIDE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 4578 | 24882357 |
US |
31 | 1 |
Overdose, Product prescribing error, |
||||
CLONAZEPAM, GABAPENTIN, OXYCODONE, |
||||
| 4579 | 24882664 |
US |
||
Fall, Flatulence, Regurgitation, Aerophagia, Gastrooesophageal reflux disease, Cough, Vomiting, Fatigue, Pyrexia, Nasopharyngitis, Product taste abnormal, Product use complaint, Overdose, Underdose, |
||||
TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, |
||||
| 4580 | 24882739 |
FI |
37 | 1 |
Somnolence, Gait disturbance, Fatigue, Asthenia, Dizziness, Speech disorder, Dyspnoea, Ill-defined disorder, Muscular weakness, Aggression, Heart rate increased, Respiratory rate increased, Confusional state, Post-injection delirium sedation syndrome, Overdose, |
||||
OLANZAPINE PAMOATE, QUETIAPINE FUMARATE, QUETIAPINE, VALPROIC ACID, |
||||
| 4581 | 24883040 |
US |
2 | |
Seizure, Cough, Head titubation, Nasal discomfort, Throat irritation, Ear discomfort, Headache, Dizziness, Drug ineffective, Product use issue, Overdose, |
||||
MIDAZOLAM, MIDAZOLAM, BRIVARACETAM, FENFLURAMINE, |
||||
| 4582 | 24883176 |
DE |
35 | 1 |
Respiratory arrest, Pulmonary oedema, Brain oedema, Respiratory depression, Toxicity to various agents, Substance abuse, Overdose, |
||||
CLONAZEPAM, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, METHADONE, OLANZAPINE, ROCURONIUM BROMIDE, AMPHETAMINE, BUPRENORPHINE, |
||||
| 4583 | 24884122 |
ES |
81 | 1 |
Peritonitis, Peritoneal cloudy effluent, Overdose, |
||||
ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
| 4584 | 24875932 |
MY |
2 | |
Somnolence, Overdose, |
||||
MORPHINE SULFATE, |
||||
| 4585 | 24875934 |
IT |
81 | 2 |
Somnolence, Overdose, |
||||
MORPHINE SULFATE, |
||||
| 4586 | 24875937 |
GB |
43 | 1 |
Substance use, Toxicity to various agents, Overdose, |
||||
MORPHINE SULFATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 4587 | 24875943 |
US |
81 | 1 |
Somnolence, Overdose, |
||||
MORPHINE SULFATE, |
||||
| 4588 | 24876214 |
GB |
||
Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 4589 | 24877242 |
US |
||
Seizure, Fall, Depression, Inappropriate schedule of product administration, Overdose, |
||||
ESLICARBAZEPINE ACETATE, |
||||
| 4590 | 24877285 |
DE |
27 | 2 |
Suicide attempt, Mean arterial pressure decreased, Acute kidney injury, Overdose, Toxicity to various agents, Drug level increased, Lethargy, Swelling face, |
||||
AMLODIPINE BESYLATE, LOSARTAN, HYDROCHLOROTHIAZIDE, |
||||
| 4591 | 24877286 |
DE |
54 | 2 |
Cardiogenic shock, Haemodynamic instability, Pulseless electrical activity, Respiratory failure, Shock, Suicide attempt, Hypothermia, Femoral artery dissection, Compartment syndrome, Renal impairment, Overdose, Toxicity to various agents, Drug level increased, Leg amputation, Peripheral ischaemia, |
||||
AMLODIPINE BESYLATE, BISOPROLOL FUMARATE, |
||||
| 4592 | 24877319 |
27 | 1 | |
Cardiac arrest, Pulseless electrical activity, Drug interaction, Bradycardia, Hypotension, Overdose, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, GUANFACINE, GUANFACINE HYDROCHLORIDE, GAUNFACINE, LACOSAMIDE, FENTANYL, FLUVOXAMINE MALEATE, GLYCOPYRROLATE, HALOPERIDOL, HALOPERIDOL LACTATE, MELATONIN, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, OLANZAPINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, |
||||
| 4593 | 24877323 |
20 | 1 | |
Confusional state, Dysarthria, Flushing, Muscle rigidity, Hyperreflexia, Lethargy, Serotonin syndrome, Sinus tachycardia, Pyrexia, Drug interaction, Tremor, Hyperhidrosis, Overdose, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, BENZTROPINE, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 4594 | 24877704 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Drug-induced liver injury, Folliculitis, Hand deformity, Insomnia, Pruritus, Psoriatic arthropathy, Rheumatoid arthritis, Systemic lupus erythematosus, Blister, C-reactive protein abnormal, Dyspnoea, Finger deformity, Lower respiratory tract infection, Malaise, Product label confusion, Rash, Stomatitis, Synovitis, Wound, Arthropathy, Coeliac disease, Gait inability, Grip strength decreased, Hypertension, Inflammation, Liver function test increased, Musculoskeletal stiffness, Type 2 diabetes mellitus, Anti-cyclic citrullinated peptide antibody positive, Confusional state, C-reactive protein increased, Drug hypersensitivity, Headache, Joint swelling, Onychomadesis, Pain, Pneumonia, Swelling, Alopecia, Blood cholesterol increased, Glossodynia, Hypersensitivity, Infusion related reaction, Injury, Pain in extremity, Pericarditis, Back injury, General physical health deterioration, Hepatic enzyme increased, Impaired healing, Nausea, Vomiting, Contusion, Duodenal ulcer perforation, Fall, Gastrointestinal disorder, Helicobacter infection, Hepatitis, Ill-defined disorder, Muscular weakness, Onychomycosis, Overdose, Rheumatic fever, Dyspepsia, Fatigue, Injection site reaction, Mobility decreased, Nail disorder, Neck pain, Pemphigus, Sleep disorder, |
||||
HYDROXYCHLOROQUINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, USTEKINUMAB, SULFASALAZINE, TOFACITINIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, LEFLUNOMIDE, PREDNISONE, LEFLUNOMIDE, AZATHIOPRINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, DESOXIMETASONE, ETANERCEPT, FOLIC ACID, ALENDRONATE SODIUM, GOLD, ADALIMUMAB, HYDROCORTISONE ACETATE, INFLIXIMAB, LEFLUNOMIDE, METHYLPREDNISOLONE, MINOCYCLINE, ABATACEPT, APREMILAST, PREDNISONE, INFLIXIMAB, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, NAPROXEN, NAPROXEN SODIUM, METHOTREXATE, METHOTREXATE SODIUM, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, CERTOLIZUMAB PEGOL, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE SULFATE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, SULFASALAZINE, TOFACITINIB, TOFACITINIB, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, RITUXIMAB, |
||||
| 4595 | 24878013 |
US |
1 | |
Wrong technique in device usage process, Overdose, |
||||
FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 4596 | 24878087 |
CN |
31 | 1 |
Serum ferritin increased, Nausea, Overdose, |
||||
| 4597 | 24878365 |
GB |
45 | 1 |
CHANTER syndrome, Overdose, |
||||
PREGABALIN, METHADONE, |
||||
| 4598 | 24878371 |
US |
68 | 2 |
Hysterectomy, Neuropathy peripheral, Oedema peripheral, Restless legs syndrome, Iron deficiency anaemia, Dry mouth, Constipation, Hyposmia, Nausea, Off label use, Overdose, |
||||
ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, ESCITALOPRAM OXALATE, ESCITALOPRAM, AMLODIPINE BESYLATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OMEPRAZOLE MAGNESIUM, ROPINIROLE, BACLOFEN, GABAPENTIN ENACARBIL, PREGABALIN, CARBIDOPA, CARBIDOPA TABLETS, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CLINDAMYCIN HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE, CLONIDINE, DICLOFENAC, DICLOFENAC SODIUM, NIFEDIPINE, |
||||
| 4599 | 24878419 |
GB |
45 | 1 |
CHANTER syndrome, Overdose, |
||||
PREGABALIN, METHADONE, |
||||
| 4600 | 24878455 |
CN |
33 | 2 |
Cystoid macular oedema, Overdose, Incorrect dose administered, Retinopathy, |
||||
HYDROXYCHLOROQUINE SULFATE, PREDNISOLONE ACETATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30